Short-form Adaptive Measure of Financial Toxicity from the Economic Strain and Resilience in Cancer (ENRICh) Study: Derivation Using Modern Psychometric Techniques
Overview
Authors
Affiliations
Objectives: This study sought to evaluate advanced psychometric properties of the 15-item Economic Strain and Resilience in Cancer (ENRICh) measure of financial toxicity for cancer patients.
Methods: We surveyed 515 cancer patients in the greater Houston metropolitan area using ENRICh from March 2019 to March 2020. We conducted a series of factor analyses alongside parametric and non-parametric item response theory (IRT) assessments using Mokken analysis and the graded response model (GRM). We utilized parameters derived from the GRM to run a simulated computerized adaptive test (CAT) assessment.
Results: Among participants, mean age was 58.49 years and 278 (54%) were female. The initial round factor analysis results suggested a one-factor scale structure. Negligible levels of differential item functioning (DIF) were evident between eight items. Three items were removed due to local interdependence (Q3>+0.4). The original 11-point numerical rating scale did not function well, and a new 3-point scoring system was implemented. The final 12-item ENRICh had acceptable fit to the GRM (p<0.001; TLI = 0.94; CFI = 0.95; RMSEA = 0.09; RMSR = 0.06) as well as good scalability and dimensionality. We observed high correlation between CAT version scores and the 12-item measure (r = 0.98). During CAT, items 2 (money you owe) and 4 (stress level about finances) were most frequently administered, followed by items 1 (money in savings) and 5 (ability to pay bills). Scores from these four items alone were strongly correlated with that of the 12-item ENRICh (r = 0.96).
Conclusion: These CAT and 4-item versions provide options for quick screening in clinical practice and low-burden assessment in research.
Kandula V, Smith G, Rajaram R, Palaskas N, Deswal A, Nasir K Methodist Debakey Cardiovasc J. 2024; 20(5):15-26.
PMID: 39525372 PMC: 11546205. DOI: 10.14797/mdcvj.1466.
Xu C, Sidey-Gibbons C, Lacourt T Qual Life Res. 2024; 33(9):2361-2373.
PMID: 38980641 PMC: 11881535. DOI: 10.1007/s11136-024-03705-0.
Liang M, Dholakia J, Lee G, Wang L, Kako T, Blair I Gynecol Oncol. 2024; 183:53-60.
PMID: 38518528 PMC: 11153034. DOI: 10.1016/j.ygyno.2024.03.014.
Financial toxicity in cancer patients and subsequent risk of repeat acute care utilization.
Shi J, Maldonado J, Wu C, Peterson S, Chen Y, Diao K Front Psychol. 2023; 14:1209526.
PMID: 37663351 PMC: 10469858. DOI: 10.3389/fpsyg.2023.1209526.
Xu C, Pfob A, Mehrara B, Yin P, Nelson J, Pusic A Ann Surg Oncol. 2023; 30(12):7046-7059.
PMID: 37516723 PMC: 10562277. DOI: 10.1245/s10434-023-13971-w.